Polymers at the Interface with Biology B iology in its broadest sense is an important model and inspiration for science and technology. In relation to polymers, biology uses a variety of complex macromolecules to accomplish a myriad of functions in living systems. These biopolymers incorporate many unique features that have inspired the polymer community, including sequence specificity, renewable feedstocks, catalytic activity, self-replication, and specific recognition. Bioinspired synthetic and biologically derived polymers are critical components of many innovative solutions aimed at addressing some of the most pressing problems related to human health and the environment. Challenges and opportunities for the polymer science community at large include both developing synthetic strategies toward such materials as well as studying and developing a fundamental understanding of their interactions with biological systems. Since its inception in 2000, Biomacromolecules has strived to become the leading forum for the dissemination of cutting-edge research at the interface of polymer science and biology. Articles published in Biomacromolecules contain strong elements of innovation in terms of macromolecular design, synthesis, and characterization or in new applications of polymers to biology and medicine.
The aims of this Editorial are to review the evolution of research at the interface of polymer science and biology and to present a forward-looking view of this field. We do this by highlighting some areas of research that have been prominently featured in Biomacromolecules over the past years and by presenting some emerging topics that we consider of great relevance and interest to the polymer science community and the readership of Biomacromolecules. This Editorial is partly based on a symposium entitled "Polymers at the Interface with Biology" and an associated "round-table" discussion that took place during the 2017 American Chemical Society (ACS) Fall Meeting in Washington, DC. The participants of this discussion included the Editor-in-Chief and Associate Editors of Biomacromolecules as well as a group of 13 invited experts.
Research at the intersection of polymer science and biology has significantly evolved over the past two decades. To illustrate this, Table 1 provides a collection of the most highly cited manuscripts published in Biomacromolecules since the start of the journal in the year 2000. Table 1 only includes original research papers, i.e., no review articles. The table illustrates how the focus of many of the most cited papers in the field has gradually shifted over time. The focus of highly cited papers that appeared between 2000 and 2006 was heavily influenced by natural biopolymers (e.g., cellulose, silk) as well as electrospinning of polymer fibers. Other highly cited manuscripts that were published in Biomacromolecules during this period include seminal work on the development of reduction-sensitive block copolymer micelles, 12 the use of "click-type" conjugate addition reactions, 9, 19 or DOPA chemistry 17 to produce functional hydrogel materials as well as the design of antibacterial surface films using surfaceinitiated controlled radical polymerization methods. 30 By comparison, many highly cited papers published in Biomacromolecules between 2007 and 2013 report on the preparation, characterization, and use of cellulose nanofibers. In addition, this era features work on the preparation of nonfouling polymer coatings 51 and also shows an increased interest in the design of pH and/or reduction-sensitive polymer nanocarriers for intracellular drug delivery 47, 64, 82, 84 as well as further examples to explore the utilization of DOPA-based chemistries for the preparation of polymer nanoparticles, 68 microcapsules, 73 and hydrogels. 80 Highly cited work from the most recent period (2014−present day) includes a number of articles focused on the development of surfaces or scaffolds designed to enhance tissue regeneration or for cell culture. 88, 89, 91 Other examples include self-healing materials, 105 mussel-inspired pH responsive hydrogels, 87 investigation of how adsorbed proteins influence cellular uptake of nanoparticles, 92 and several studies on pH, redox, temperature, and light-responsive polymer particles designed to facilitate intracellular or intratumoral drug release. 86, 90, 94, 100 Although the highly cited papers listed in Table 1 and highlighted above reflect topics that have generated significant interest, it is also important to recognize that they, of course, are not exclusively representative of the content published in Biomacromolecules. As is evident also from Table 1 , research fields continuously evolve, and Biomacromolecules aims to capture new and exciting work at the forefront of the field.
One important objective of the "Polymers at the Interface with Biology" symposium was to develop a forward-looking view of the field and highlight emerging topics that are of particular interest to the readership of Biomacromolecules. Many interesting topics relevant to this theme were presented by the speakers at the symposium in Washington, DC. One example is the diverse field of biorelated synthetic polymers, which includes those based on natural biopolymers, such as polypeptides, polynucleic acids, and polysaccharides, as well as those that mimic nature, including polypeptoids and other peptidomimetics, polymers from biological feedstocks, and sequence-controlled polymers.
For the field of biosourced sustainable polymers, Prof. Eugene Chen discussed and emphasized the importance of enhancing the thermal and mechanical properties of bioderived synthetic polyesters and also realizing the potential to chemically recycle these polymers back to their constituent monomers. He reported catalytic systems capable of preparing such polyesters with enhanced properties via ring-opening polymerization of γ-butyrolactone and its derivatives, as well as the methodology that permits their complete depolymerization back to the original building blocks. 109−111 Polymers containing functional side-chains and possessing the ability to respond to different stimuli continue to be developed as functional and structural mimics of biological polymers and assemblies. Related to this theme, Prof. Steven Armes presented the synthesis of pH-responsive triblock copolymers designed to self-assemble into framboidal vesicles that were capable of mimicking the structural features and pH-triggered morphological transitions of certain viruses, e.g., the Dengue virus. Engineered biorelated polymers, such as recombinant proteins and polymers produced using biocatalysis, are another core area for Biomacromolecules. In the symposium, Prof. Jan van Hest described engineered chimeric proteins composed of elastin-like segments and cowpea chlorotic mottle virus subunits and their assembly into nanostructures that form biomimetic structures capable of responding to pH, temperature, and salt. These assemblies take advantage of the stimuliresponsive properties of elastin sequences, and the precision subunit assembly features of viral proteins. 112−114 Related to this theme, Prof. Julie Champion discussed the design and preparation of protein constructs containing segments composed of coiled-coil and antibody binding motifs that enable them to assemble into well-defined nanostructures capable of binding and presenting antibodies. These nanocarriers are being evaluated for the intracellular delivery of therapeutic antibodies. 115 Beyond synthesis and structure, understanding the properties and dynamics of biorelated polymer assemblies is also central to the scope of Biomacromolecules. Prof. Monica Olvera de la Cruz studies how multivalent ions and polymers can interact with amphiphilic molecules to form different morphologies with diverse chemical functionality. 116−119 Modeling of such systems can lead to the discovery of new functional structures that can mimic biological functions. In studies aimed at mimicking coacervate formation observed with intrinsically disordered proteins in membraneless organelles within cells, Prof. Matthew Tirrell presented studies on complex coacervation of oppositely charged synthetic polyelectrolytes where a variety of features, including polymer stereochemistry, polymer chain length, and solution ionic strength were found to influence polyelectrolyte complex phase separation. 120 These insights into protein/polyelectrolyte complexation show promise for the design of new biomimetic materials. 121 An obstacle that presents a significant hurdle toward the clinical implementation of polymers and polymer-based nanomaterials for drug delivery applications is a lack of reproducible and scalable synthetic protocols. Polymer nanoparticles, as an example, are typically obtained via multiple formulation and modification steps. To overcome these challenges, Prof. Jeremiah Johnson described the preparation of macromolecular prodrugs starting from complex, small building blocks, which are accessible via organic synthesis. 122−125 These small building blocks are then assembled together, for example, using ring-opening metathesis polymerization (ROMP), into the desired nanomaterial, thereby decoupling synthetic complexity and scalability.
Polymers and polymer nanoparticles are widely acknowledged for their ability to prolong the blood circulation time of therapeutics and to facilitate targeted delivery (e.g., to a tumor in cancer therapy). In addition to controlling plasma half-life and enabling targeted delivery of therapeutics, another pressing problem, in particular for biologics (such as peptide-, protein-, or nucleotide-based actives), is their stability during shipping and storage. 126 This is a fundamental research problem, yet one with enormous impact in those parts of the world where an effective and reliable cold chain from the manufacturer to the patient is absent. Addressing this challenge, Prof. Heather Maynard emphasized the need for improved polymers for protein stabilization, especially for prolonged storage, and presented functional polymer designs, some also degradable, that enabled protein protection to heat and mechanical agitation. The polymers could be conjugated to proteins and peptides, added as excipients, or used to surround the biologic as a nanoparticle for potential use in medicine. 127−133 Considerable research over the past few decades has accumulated an increasingly robust understanding of the behavior of polymers and polymer nanoparticles in blood circulation as well as mechanisms for their cellular uptake. Fundamental design principles to control properties such as plasma half-life or to promote cellular internalization have been established for the preparation of more effective polymer nanomedicines. However, because the target for many active compounds is a specific cellular organelle, understanding and controlling the behavior of polymer nanomedicines at the subcellular level remains an important challenge. Aimed at addressing this issue, Prof. Millicent Sullivan and co-workers developed light-sensitive mPEG-b-poly(5-(3-(amino)propoxy)-2-nitrobenzyl methacrylate) polymers to deploy nucleic acids into cells with "on/off" control over the timing and amount of delivery and spatial control at cellular length scales. 134−138 In addition to their utility for drug delivery, polymers and polymer assemblies also possess great potential for use in the broad realm of immunotherapy, including the targeted delivery of immunomodulatory drugs or vaccines to lymphoid organs or tumors. Prof. Darrell Irvine presented the use of polymerbased amphiphiles to increase the safety and potency of immunotherapies. Initially, these polymer amphiphiles were used to bind antigens and adjuvants to albumin. 139, 140 Next, these amphiphiles were designed to associate with a stimulator of interferon genes (STING) agonist and assemble into nanofibers or nanodiscs that may be administered locally or systemically. Another strategy that underlines the potential of polymer science to advance immunotherapy was presented by Prof. Laura Kiessling, who described polymers that target antigens to dendritic cells. 141 These polymers exploit the features of lectins, which are important for the recognition, uptake, and processing of antigens. 142 She reported that the fate of glycosylated antigens in dendritic cells is affected by their physical properties (e.g., size, length), which can be altered using controlled polymerization techniques. These parameters define how polymers can be used to deliver antigens to dendritic cells to avoid immune detection or to promote immunity.
In addition to the diagnosis and treatment of human diseases, another important medical application for polymerbased materials is in the repair or regeneration of damaged or lost tissue. A particularly challenging problem in this context is bone defect generation because it requires polymers that are exceptionally strong and at the same time can also degrade at designed intervals. Prof. Matthew Becker presented a class of α-amino acid based poly(ester urea)s (PEUs) that were designed for this purpose. 143 One of the keys to the successful development of these materials was optimized step polymerization protocols and functionalization strategies, which afforded high molecular weight materials and provided excellent synthetic flexibility. 144 In sheep segmental tibia defect models, the use of scaffolds fabricated from these PEU polymers allowed near complete defect healing within 16 weeks.
Minimally invasive soft tissue regeneration demands hydrogels that provide mechanical protection to cells during injection that are also able to adapt to accommodate local cell remodeling of the polymer network. 145 toward such materials was presented by Prof. Sarah Heilshorn who described a new class of double-network hydrogels. Prior to injection, these materials are cross-linked ex situ by the formation of dynamic covalent hydrazone bonds that result from mixing a hydrazine-modified elastin-like polypeptide (ELP) and an aldehyde-modified hyaluronic acid. In situ, after injection, thermoresponsive aggregation of the ELP reinforces the network resulting in a hydrogel matrix that possesses viscoelastic stress-relaxation behavior. 147 These topics presented in Washington, DC highlight some of the research directions at the forefront of polymer science and biology and represent areas and communities Biomacromolecules aims to serve. These fields are dynamic: new synthetic methodologies are being developed; more accurate characterization tools become available, and biology moves to smaller and smaller length-scales and becomes more quantitative. With these changes, and as new important societal challenges arise, Biomacromolecules endeavors to adapt to include emerging themes and scientific breakthroughs at the interface of polymer science and biology. 
